Literature DB >> 2771363

Magnetic resonance imaging versus computed tomography of leukocoric eyes and use of in vitro proton magnetic resonance spectroscopy of retinoblastoma.

M F Mafee1, M F Goldberg, S B Cohen, E D Gotsis, M Safran, L Chekuri, B Raofi.   

Abstract

To evaluate the usefulness of magnetic resonance imaging (MRI) in the evaluation of leukocoric eyes, the authors studied 28 patients with either leukocoria or intraocular mass with a 1.5-tesla (T) MRI imager. Retinoblastomas were reliably distinguished from Coats' disease, toxocariasis, and persistent hyperplastic primary vitreous on the basis of MRI findings. Calcification cannot be reliably detected on MRI scans. Lesions elevated less than 4 mm may not be detected reliably by MRI at this time. Computed tomography (CT) can detect calcification with a high degree of accuracy. Retinoblastomas appeared as moderately hyperintense masses on T1- and proton-weighted MRIs. They became hypointense in T2-weighted MRIs. This MRI characteristic is similar to that of uveal melanoma. Intraocular calcification in children especially younger than 3 years of age is highly suggestive of retinoblastoma. In the diagnosis of retinoblastoma, MRI is not as specific as CT because of its lack of sensitivity in detecting calcification. However, MRI, because of its superior contrast resolution, offers more information in the differentiation of pathologic intraocular conditions responsible for leukocoria. The authors also describe their preliminary work of in vitro proton magnetic resonance spectroscopy of eyes with retinoblastoma and an eye with uveal melanoma in an 18-year-old black woman.

Entities:  

Mesh:

Year:  1989        PMID: 2771363     DOI: 10.1016/s0161-6420(89)32773-4

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  9 in total

1.  Retinoblastoma - MR appearance using a surface coil in comparison with histopathological results.

Authors:  Arne-Jörn Lemke; Iris Kazi; Ulrike Mergner; Paul Ivan Foerster; Heinrich Heimann; Nikolaos Bechrakis; Andreas Schüler; Marie-Isabell Senfft von Pilsach; Michael Foerster; Roland Felix; Norbert Hosten
Journal:  Eur Radiol       Date:  2006-04-25       Impact factor: 5.315

2.  Reversible leukocoria associated with clinically significant diabetic macular edema.

Authors:  L P Aiello; P G Arrigg; L M Aiello
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1995-01       Impact factor: 3.117

Review 3.  Nuclear magnetic resonance spectroscopy. Principles and applications in neuroophthalmology.

Authors:  A Ettl; C Fischer-Klein; A Chemelli; A Daxer; S Felber
Journal:  Int Ophthalmol       Date:  1994       Impact factor: 2.031

Review 4.  Applications of monoclonal antibodies in the investigation, diagnosis, and treatment of retinoblastoma.

Authors:  J F Tarlton; D L Easty
Journal:  Br J Ophthalmol       Date:  1993-12       Impact factor: 4.638

5.  MR imaging in retinoblastoma.

Authors:  F Barkhof; M Smeets; P van der Valk; K E Tan; F Hoogenraad; J Peeters; J Valk
Journal:  Eur Radiol       Date:  1997       Impact factor: 5.315

6.  Detection of calcifications in retinoblastoma using gradient-echo MR imaging sequences: comparative study between in vivo MR imaging and ex vivo high-resolution CT.

Authors:  F Rodjan; P de Graaf; P van der Valk; T Hadjistilianou; A Cerase; P Toti; M C de Jong; A C Moll; J A Castelijns; P Galluzzi
Journal:  AJNR Am J Neuroradiol       Date:  2014-12-18       Impact factor: 3.825

Review 7.  Orbital sonography in children.

Authors:  F G Ramji; T L Slovis; J D Baker
Journal:  Pediatr Radiol       Date:  1996

8.  Retinoblastoma: CT and MRI.

Authors:  R G Beets-Tan; M J Hendriks; L M Ramos; K E Tan
Journal:  Neuroradiology       Date:  1994       Impact factor: 2.804

Review 9.  Advanced Coats' disease.

Authors:  B G Haik
Journal:  Trans Am Ophthalmol Soc       Date:  1991
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.